EUVIMEDEUVIMED entdecken
Open Access

Prognostic Role of Prostate-specific Antigen Isoforms and Their Early Kinetics in Patients With Metastatic Castration-resistant Prostate Cancer Receiving New Generation Androgen Receptor Targeted Agents

Ondřej Fiala, Petr Hošek, Hana Korunková, Michaela Tkadlecová, Milan Hora, Dominika Šiková, Petr Stránský, Jindřich Fínek, Radek Kučera, Jindra Windrichová, Ondřej Topolčan

In Vivo · 2025-03 · 39 (2) · 859-869

DOI: 10.21873/invivo.13889 ↗

Kurz gefasst

Fachartikel in der Zeitschrift In Vivo, online erschienen am 26.02.2025. Verfasst von Ondřej Fiala und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology and Radiotherapeutics, Faculty of Medicine and University Hospital in Pilsen, Charles University, Pilsen, Czech Republic; fial…. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Castration-Resistant, Prostate-Specific Antigen, Receptors, Androgen. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic Neoplasms, Castration-ResistantProstate-Specific AntigenReceptors, AndrogenMaleHumansAgedPrognosisProtein IsoformsMiddle AgedBenzamidesNitrilesPhenylthiohydantoinRetrospective StudiesBiomarkers, TumorAbiraterone AcetateAged, 80 and overNeoplasm MetastasisROC CurveTreatment Outcome

Stichwörter der Autor:innen

(−2)proPSAARTACastration-resistant prostate cancerPSAabiraterone acetateenzalutamidefree PSA

Substanzen

Prostate-Specific AntigenProtein IsoformsBenzamidesNitrilesReceptors, AndrogenenzalutamidePhenylthiohydantoinBiomarkers, TumorAbiraterone Acetate

Autor:innen und Institutionen

  • Department of Oncology and Radiotherapeutics, Faculty of Medicine and University Hospital in Pilsen, Charles University, Pilsen, Czech Republic; fialao@fnplzen.cz.
  • Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic.
  • Oncology Ambulance, Karlovy Vary Regional Hospital, Karlovy Vary, Czech Republic.
  • Institute of Radiation Oncology, Bulovka University Hospital and 1 Medical Faculty, Charles University, Prague, Czech Republic.
  • Department of Oncology and Radiotherapeutics, Faculty of Medicine and University Hospital in Pilsen, Charles University, Pilsen, Czech Republic.
  • Department of Urology, Faculty of Medicine and University Hospital in Pilsen, Charles University, Pilsen, Czech Republic.

Zitieren

APA

Fiala, O., Hošek, P., Korunková, H., Tkadlecová, M., Hora, M., Šiková, D., Stránský, P., Fínek, J., Kučera, R., Windrichová, J., & Topolčan, O. (2025). Prognostic Role of Prostate-specific Antigen Isoforms and Their Early Kinetics in Patients With Metastatic Castration-resistant Prostate Cancer Receiving New Generation Androgen Receptor Targeted Agents. In Vivo, 39(2), 859-869. https://doi.org/10.21873/invivo.13889

Vancouver

Fiala O, Hošek P, Korunková H, Tkadlecová M, Hora M, Šiková D, et al. Prognostic Role of Prostate-specific Antigen Isoforms and Their Early Kinetics in Patients With Metastatic Castration-resistant Prostate Cancer Receiving New Generation Androgen Receptor Targeted Agents. In Vivo. 2025;39(2):859-869. doi:10.21873/invivo.13889

BibTeX
@article{Fiala2025,
  author = {Fiala, Ondřej and Hošek, Petr and Korunková, Hana and Tkadlecová, Michaela and Hora, Milan and Šiková, Dominika and Stránský, Petr and Fínek, Jindřich and Kučera, Radek and Windrichová, Jindra and Topolčan, Ondřej},
  title = {Prognostic Role of Prostate-specific Antigen Isoforms and Their Early Kinetics in Patients With Metastatic Castration-resistant Prostate Cancer Receiving New Generation Androgen Receptor Targeted Agents},
  journal = {In Vivo},
  year = {2025},
  volume = {39},
  number = {2},
  pages = {859--869},
  doi = {10.21873/invivo.13889}
}
Kostenlos starten →